SB
RVMD icon

SIG Brokerage’s Revolution Medicines RVMD Stock Holding History

SIG Brokerage’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,000
Closed -$239K – 940
2025
Q4 		$239K Buy
+3,000
New +$197K 0.01% 570
2025
Q1 		– Sell
-14,800
Closed -$647K – 694
2024
Q4 		$647K Buy
+14,800
New +$747K 0.03% 298

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SIG Brokerage's RVMD Position: Q4 2025 in Review

SIG Brokerage sold out of Revolution Medicines (RVMD) in Q4 2025, closing a stake of 10,411 shares — an estimated $683K sold.

SIG Brokerage first reported a position in RVMD in Q1 2025 and held it in 3 quarters. The position peaked at $493K in Q2 2025. 386 funds tracked by Wall St. Rank hold RVMD as of Q4 2025.

  • SIG Brokerage reported no remaining Revolution Medicines position as of Q4 2025 after selling out during the quarter.
  • SIG Brokerage sold 10,411 Revolution Medicines shares in Q4 2025, an estimated $683K.
  • SIG Brokerage first reported a position in Revolution Medicines in Q1 2025 and held it in 3 quarters.
  • SIG Brokerage's Revolution Medicines position peaked at $493K in Q2 2025.
  • 386 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2025.

Based on SIG Brokerage's 13F filing for Q4 2025, filed 17 Feb 2026.